France, Sofinnova Partners Closes $260M Venture Capital Fund

Sofinnova Partners, a Paris, France-based venture capital firm, closed its sixth fund, Sofinnova Capital VI, raising €260m.

Investors in Sofinnova Capital VI include CDC Entreprises, Industrial & Financial Investments Co., JP Morgan Asset Management, funds advised by Partners Group and Skandia Life Insurance Company.

Sofinnova Capital VI already invested in eight start-ups and spinoffs, in disruptive technologies in healthcare therapeutics, medical devices, green chemistry, in wireless and mobile technologies, all led by experienced entrepreneurs and management.

These deals include

- Celsius (France/Switzerland),

- CoAxia, Inc. (USA),

- Crescendo Biologics Ltd (UK),

- DNP Green Technology, Inc. (Canada/France),

- Flexion Therapeutics AG (Switzerland/USA),

- MD Start (Switzerland),

- Mydeco (UK) and

- Sagem Wireless (France).

FinSMEs

26/01/2010